Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/148129
Title: Behavioral addictions in bipolar disorders: A systematic review
Author: Varo, Cristina
Murru, Andrea
Salagre, Estela
Jiménez Martínez, Ester
Solé, Brisa
Montejo, Laura
Carvalho, André F.
Stubbs, Brendon
Grande, Iria
Martínez-Arán, Anabel, 1971-
Vieta i Pascual, Eduard, 1963-
Reinares, María
Keywords: Trastorn bipolar
Anàlisi de conducta
Comorbiditat
Manic-depressive illness
Behavioral assessment
Comorbidity
Issue Date: Jan-2019
Publisher: Elsevier B.V.
Abstract: Clinical and epidemiological research suggests that behavioral addictions (BA) are associated with a wide range of psychiatric disorders. However, the relationship between BA and bipolar disorders (BD) has not been thoroughly explored. The aim of this systematic review was to critically summarize and evaluate the current available evidence regarding a possible association between BA and BD. A systematic review of major electronic databases according to PRISMA guidelines was conducted from inception to 31st December 2017. We sought quantitative studies data concerning prevalence of comorbidity, features and treatment related to BA-BD comorbidity. Data were narratively synthesized. Of the 1250 studies returned from the search, a total of 28 articles were included in this review. BA may be overrepresented in BD samples, and the other way around. Pathological gambling and kleptomania were the most prevalent conditions followed by compulsive buying, compulsive sexual behavior and internet addiction. BA was also associated with other mood disorders, anxiety disorders and substance use disorder. BD-BA comorbidity was related with more severe course of illness. Studies on treatment strategies for BD-BA comorbidity are rather limited; only one randomized controlled trial that fulfilled inclusion criteria was identified. Methodological heterogeneity in terms of design and results among studies was found. BD-BA commonly co-occurs although there is a need for rigorous studies. Routine screening and adequate assessment may be helpful in BD patients to identify individuals at risk for BA and to effectively manage the complex consequences associated with BA-BD comorbidity.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2018.10.012
It is part of: European Neuropsychopharmacology, 2019, vol. 29, num. 1, p. 76-97
URI: http://hdl.handle.net/2445/148129
Related resource: https://doi.org/10.1016/j.euroneuro.2018.10.012
ISSN: 0924-977X
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (Psicologia Clínica i Psicobiologia)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
683032.pdf823.96 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons